Plasma Vasopressin, Catecholamines and Atrial Natriuretic Factor During Hemodialysis and Sequential Ultrafiltration

REFERENCES

• Andersson U, Sylvén C, Lindvall K, Theodorsson E, Noree L-O. Cardiac function and cardiovascular hormone balance during hemodialysis with special reference to atrial natriuretic peptide. Clin Nephrol 1988; 30: 303–307.
   PubMed Web of Science ®Google Scholar
• Ando R, Matsuda O, Miyake S, Yoshiyama N. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 1988: 50: 225–228.
   PubMed Web of Science ®Google Scholar
• Benmansour M, Rainfray M, Paillard F, Ardaillou R. Metabolic clearance rate of immunoreactive vasopressin in man. Eur J Clin Invest 1982: 12: 475–480.
   PubMed Web of Science ®Google Scholar
• Bergstrôm J, Asaba H, Furst P, Oules R. Dialysis, ultrafiltration and blood pressure. Proc EDTA 1976; 13: 293–305.
   Google Scholar
• Bunag RD, Page IH, McCubbin JW. Inhibition of renin release by vasopressin and angiotensin. Cardiovasc Res 1967: 1: 67–73.
   PubMedGoogle Scholar
• Caillens H, Pruszczynski W, Meyrier A, Ang K-S, Rousselet F, Ardaillou R. Relationship between change in volemia at constant osmolality and plasma antidiuretic hormone. Mineral Electrolyte Metab 1980; 4: 161–171.
   Google Scholar
• Campese VC, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic dysfunction in uremia. Kidney Int 1981; 20: 246–253.
   PubMed Web of Science ®Google Scholar
• Cernacek P, Crawhall JC, Levy M. Atrial natriuretic peptide: Blood levels in human disease and their measurements. Clin Biochem 1988; 21: 5–17.
   PubMed Web of Science ®Google Scholar
• Claybaugh JR, Share L. Vasopressin, renin, and cardiovascular response to continuous slow hemorrhage. Am J Physiol 1973; 224: 519–523.
   PubMed Web of Science ®Google Scholar
• Crozier IG, Nicholls MG, Ikram H, Espiner EA, Yandle TG, Jans S. Atrial natriuretic peptide in humans. Production and clearance by various tissues. Hypertension 1986: 8 (suppl II) II-11–5.
   Google Scholar
• Cuche JL, Prinseau J, Selz F, Ruget G, Baglin A. Plasma free sulfo- and glucuro-conjugated catecholamines in uraemic patients. Kidney Int 1986: 30: 566–572.
   PubMed Web of Science ®Google Scholar
• d'Amore TF, Wauters JP, Waeber B, Nusseberger J, Brunner HR. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis. Clin Nephrol 1985; 23: 299–302.
   PubMed Web of Science ®Google Scholar
• Elias AN, Vaziri ND, Maksy M. Plasma norepinephrine, epinephrine and dopamine levels in end-stage renal disease. Effect of haemodialysis. Arch Intern Med 1985: 145: 1013–1015.
   PubMedGoogle Scholar
• Goetz KL, Bond GC, Smith WE. Effect of moderate hemorrhage in humans on plasma ADH and renin. Proc Soc Exp Biol Med 1974; 145: 277–280.
   PubMed Web of Science ®Google Scholar
• Hammer M, Dawids S, Bredgaard M, Sorensen M, Christensen O, Ôlgaard K. Hormonal response to volume depletion in non-nephrectomized patients on regular hemodialysis. Proc EDTA 1979: 16: 252–260.
   Google Scholar
• Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986: 63: 819–822.
   PubMed Web of Science ®Google Scholar
• Iitake K, Kimura T, Matsui K, Ota K, Shoji M, Inoue M, Yoshinaga K. Effect of haemodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with endstage renal disease. Acta Endocrinologica 1985; 110: 207–213.
   PubMedGoogle Scholar
• Kersh ES, Kronfield SJ, Under A, Popper RW, Cantor S, Cohn K. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974: 290: 650–653.
   PubMed Web of Science ®Google Scholar
• Kjeldsen SE, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. Scand J Clin Lab Invest 1982: 42: 217–223.
   PubMed Web of Science ®Google Scholar
• Kojima S, Inoue I, Hirata Y, Kimura G, Saito F, Kawano Y, Satani M, Ito K, Omae T. Plasma concentrations of immunoreactive-atrial natriuretic polypeptide in patients on hemodialysis. Nephron 1987: 46: 45–48.
   PubMed Web of Science ®Google Scholar
• Lilley JJ, Golden J, Stone RA. Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest 1976; 57: 1190–1200.
   PubMed Web of Science ®Google Scholar
• Maxwell D, McCurry S, Szwed J, Shelton R, Robertson G. The effect of distribution and clearance of vasopressin in man. Clin Res 1976; 14: 407A.
   Google Scholar
• McGrath BP, Ledingham JCG, Benedict CR. Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. Clin Sci Mol Med 1978: 55: 89–96.
   PubMedGoogle Scholar
• Os I, Kjeldsen SE, Aakesson I, Skjôtô J, Westheim A, Eide I, Leren P. Arteriovenous difference of plasma vasopressin in normal man and effect of posture. Acta Physiol Scand 1984; 122: 49–53.
   PubMedGoogle Scholar
• Os I, Kjeldsen SE, Skjôtô J, Westheim A, Lande K, Aakesson I, Frederichsen P, Leren P, Hjermann I, Eide IK. Increased plasma vasopressin in low renin essential hypertension. Hypertension 1986: 8: 506–513.
   PubMed Web of Science ®Google Scholar
• Robertson GL, Mahr EA, Athar S, Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human. J Clin Invest 1973; 52: 2340–2352.
   PubMed Web of Science ®Google Scholar
• Saxenhofer H, Gnadinger MP, Weidman P, Shaw S, Schohn D, Hess C, Uehlinger DE, Jahn H. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney International 1987; 32: 554–561.
   PubMedGoogle Scholar
• Shimamoto K, Watarai I, Miyahara M. A study of plasma vasopressin in patients undergoing chronic hemodialysis. J Clin Endocrinol Metab 1977; 45: 714–720.
   PubMed Web of Science ®Google Scholar
• Sugawara A, Nakao K, Sakamoto M et al. Plasma concentration of ANP in essential hypertension. Lancet 1985: ii: 1426–1427.
   Google Scholar
• Sundsfjord JA. Radioimmunological determination of plasma renin activity during the menstrual cycle and during acute progesterone administration. Acta Endocrinol 1971; 67: 174–186.
   PubMedGoogle Scholar
• Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci 1986; 71: 157–160.
   Web of Science ®Google Scholar
• Zoccali C, Ciccarelli M, Maggiore Q. Defective reflex control of heart rate in dialysis patients: Evidence for an afferent automic lesion. Clin Sci 1982: 63: 285–292.
   PubMed Web of Science ®Google Scholar
• Zuchelli P, Catizone L, Esposti ED, Fusardi M, Ligabue A, Zuccala A. Influence of ultrafiltration on plasma renin activity and the adrenergic system. Neprhon 1978: 21: 317–324.
   Google Scholar